T
TRYP Therapeutics Inc
CNSX:TRYP
TRYP Therapeutics Inc
CNSX:TRYP
Price:
0.06
CAD
Market Closed
Market Cap:
CA$5.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
TRYP Therapeutics Inc
CNSX:TRYP
|
CA |
|
Yesco Holdings Co Ltd
KRX:015360
|
KR |
|
Valero Energy Corp
NYSE:VLO
|
US |
|
M
|
Medtronic PLC
SWB:2M6
|
IE |
|
C
|
Chaosua Foods Industry PCL
SET:CHAO
|
TH |
|
TF Bank AB
STO:TFBANK
|
SE |
|
SkiStar AB
STO:SKIS B
|
SE |
|
C
|
Colowide Co Ltd
TSE:7616
|
JP |
|
E
|
Ecomate Holdings Bhd
KLSE:ECOMATE
|
MY |
|
L
|
Leaddesk Oyj
OMXH:LEADD
|
FI |
|
Burcelik Vana Sanayi ve Ticaret AS
IST:BURVA.E
|
TR |
|
Traction AB
STO:TRAC B
|
SE |
|
Hawkins Inc
NASDAQ:HWKN
|
US |
|
Inaba Seisakusho Co Ltd
TSE:3421
|
JP |
|
Jammu and Kashmir Bank Ltd
BSE:532209
|
IN |
|
R
|
Raute Oyj
OMXH:RAUTE
|
FI |
Cash Flow Statement
Cash Flow Statement
TRYP Therapeutics Inc
TRYP Therapeutics Inc
Currency: CAD
| Feb-2021 | May-2021 | Aug-2021 | Nov-2021 | Feb-2022 | May-2022 | Aug-2022 | Nov-2022 | Feb-2023 | May-2023 | Aug-2023 | Nov-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||
| Net Income |
(3)
|
(6)
|
(8)
|
(11)
|
(10)
|
(8)
|
(7)
|
(6)
|
(6)
|
(6)
|
(5)
|
(5)
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
|
| Other Non-Cash Items |
2
|
3
|
4
|
4
|
2
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
1
|
0
|
|
| Cash from Operating Activities |
(2)
N/A
|
(3)
-99%
|
(5)
-56%
|
(7)
-29%
|
(7)
-14%
|
(7)
+11%
|
(6)
+12%
|
(5)
+11%
|
(4)
+31%
|
(4)
+1%
|
(4)
-2%
|
(4)
+0%
|
|
| Investing Cash Flow | |||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
N/A
|
(0)
-45%
|
(0)
-32%
|
(0)
-147%
|
(0)
-66%
|
(0)
-3%
|
(0)
+15%
|
(0)
+41%
|
(0)
+65%
|
(0)
+66%
|
0
N/A
|
|
| Financing Cash Flow | |||||||||||||
| Net Issuance of Common Stock |
9
|
10
|
8
|
8
|
1
|
4
|
4
|
4
|
3
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
5
|
|
| Other |
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
8
N/A
|
9
+4%
|
8
-11%
|
8
+3%
|
1
-82%
|
4
+175%
|
4
+4%
|
4
-1%
|
3
-24%
|
2
-33%
|
2
+4%
|
5
+124%
|
|
| Change in Cash | |||||||||||||
| Net Change in Cash |
7
N/A
|
5
-18%
|
3
-51%
|
1
-48%
|
(6)
N/A
|
(3)
+55%
|
(2)
+34%
|
(1)
+35%
|
(1)
+54%
|
(2)
-178%
|
(1)
+2%
|
1
N/A
|
|
| Free Cash Flow | |||||||||||||
| Free Cash Flow |
(2)
N/A
|
(3)
-98%
|
(5)
-56%
|
(7)
-29%
|
(8)
-15%
|
(7)
+10%
|
(6)
+12%
|
(5)
+11%
|
(4)
+31%
|
(4)
+2%
|
(4)
-1%
|
(4)
+0%
|
|
Switch to:
Switch to:
See Also
Discover More
